ReviewCardiovascular diagnosis and therapy2018
Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.
Review in Cardiovascular diagnosis and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 35 citations in OpenAlex.
- Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia: Unique Intersection of Hemorrhage, Cyanosis, and Thrombosis.JACC. Case reports · 2026Article
- Anatomical and morphological predictors of pulmonary arteriovenous malformation recanalisation following embolisation: a retrospective cohort study.CVIR endovascular · 2026Article
- Article
- Beyond the Usual Suspects: Rare Causes of Hemoptysis.Diagnostics (Basel, Switzerland) · 2026Review
- Article
- Beyond epistaxis: cascade screening and presymptomatic treatment of hereditary hemorrhagic telangiectasia.BMC pediatrics · 2026Article
- The development of intrapulmonary shunting caused by luspatercept in low grade myelodysplastic syndrome: a case report.AME case reports · 2026Article
- A case of hereditary hemorrhagic telangiectasia with hypoxemia onset in the neonatal period.BMC pulmonary medicine · 2025Article
- Article
- Pulmonary arteriovenous malformations with suspected infiltrative disease: A case report from a peripheral hospital.Global cardiology science & practice · 2025Article
- Imaging in hepatopulmonary syndrome-case report. A multicenter approach during the coronavirus pandemic.Journal of radiology case reports · 2023Article
- Pulmonary Arteriovenous Malformation in a Rare Case of Hereditary Hemorrhagic Telangiectasia.Cureus · 2022Article
- Hereditary Hemorrhagic Telangiectasia-A Case Series Experience from a Liver Transplant Center in Romania.Diagnostics (Basel, Switzerland) · 2022Article
- Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management.Journal of clinical medicine · 2022Review
- Childhood stroke.Nature reviews. Disease primers · 2022Review
- Brain abscess associated withIDCases · 2022Article
- Pulmonary arteriovenous malformation with unexplained cyanosis as the first presentation of hereditary haemorrhagic telangiectasia, case report, and literature review.European heart journal. Case reports · 2021Article
- Hypoxemia without Respiratory Distress: Hereditary Hemorrhagic Telangiectasia in a Child.Journal of pediatric intensive care · 2021Article
- Applicability of Transthoracic Contrast Echocardiography for the Diagnosis and Treatment of Idiopathic Pulmonary Arteriovenous Malformations.Frontiers in cardiovascular medicine · 2021Article
- Pulmonary arteriovenous malformation in a pediatric patient with epistaxis and hypoxemia.Radiology case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Nearly half of patients with HHT will have pulmonary arteriovenous malformations (PAVM) that place them at risk for potentially fatal complications that can occur when blood bypasses the pulmonary capillary circulation or as a result of PAVM rupture. Other manifestations of HHT outside the lung may increase the rate and severity of PAVM complications, creating unique clinical challenges. Management hinges on timely screening and diagnosis, followed by treatment of amenable PAVMs with transcatheter embolization in conjunction with medical management and prophylactic measures to treat and prevent complications. The purpose of this review is to highlight the clinical manifestations of PAVMs specific to patients with HHT and to detail screening and treatment strategies that can reduce the risk of developing life-threatening complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.